common.study.topics.clinical

Detection of Tumor DNA in Blood Samples from Cancer Patients

common.study.values.description

Detection of Tumor DNA in Blood Samples From Cancer Patients

The aim of this study is to employ genomic detection methodologies to measure the relative amount of tumor nucleic acids in the blood of a cancer patient with diagnosed metastatic disease that is either commencing, currently undergoing or completed cytotoxic chemotherapy treatment. More generally, this approach will allow us to develop a quantitative measure of therapy efficacy via the counting of the relative changes in tumor molecules over the course of treatment.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Diagnostic Test - Blood test

No intervention except to collect blood for diagnostic test development

participant.views.study.view.additional

participant.views.study.view.scientific-title

Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and "Healthy Controls"

common.study.values.clinical-trial-id

NCT02288754

participant.views.study.view.id

9avYge